Biologically active formulation
US10149478B2 · kind B2 · utility
0Cited by
8References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2017 |
| Grant date | Dec 11, 2018 |
| Priority date | — |
| Expiry date | Aug 24, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01N47/40
- WIPO fieldBasic materials chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a formulation characterised by the simultaneous presence in cyclodextrin based supramolecular complexes, of two components, one of which is a neonicotinoid selected from the group consisting of Thiacloprid and Thiamethoxam and the other possesses an activity synergistic with the first, enhancing its effectiveness. The synergistic component that is able to synergistically enhance the activity of the active principle is piperonyl butoxide, and. Processes for preparing said formulation and its use for the activities herein indicated are further aspects of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.